ImmuPharma non-exec reduces stake

Dr Ajay Agrawal, Non-Executive Director of ImmuPharma, sold a stack of shares in the AIM-listed drug company, it was announced Monday.Agrawal traded in 62,169 shares at 57p a time on January 24th, pocketing £35,436 before tax. The deal was announced the same day the group said its key scientific collaboration partner and the inventor of ImmuPharma's lead compound, Lupuzor, has confirmed the effectiveness of a product known as Lupuzor peptide P140. Partner CNRS released a statement saying that in a clinical trial involving 149 patients suffering with the Lupus, an autoimmune disease, the peptide was well tolerated by patients and led to a regression of the disease. Top Director BuysBank of America Corp. (BAC) Director name: Mr R David YostAmount purchased: 20,000 @ $11.53 Value: $230,600Magnolia Petroleum (MAGP) Director name: Mr Ronald Sanford HarwoodAmount purchased: 850,000 @ 2.90p Value: £24,650Magnolia Petroleum (MAGP) Director name: Mr Steven Otis SneadAmount purchased: 500,000 @ 2.90p Value: £14,500XCAP Securities (XCAP) Director name: Mr Nitin Parekh Amount purchased: 4,750,000 @ 0.25p Value: £11,875Top Director SellsDomino Printing Sciences (DNO) Director name: Mr Nigel R BondAmount sold: 38,139 @ 648.90p Value: £247,484Experian (EXPN) Director name: Mr Brian Cassin Amount sold: 15,977 @ 1,099.00p Value: £175,587Domino Printing Sciences (DNO) Director name: Mr Andrew C HerbertAmount sold: 23,252 @ 648.90p Value: £150,882Domino Printing Sciences (DNO) Director name: Mr Garry HavensAmount sold: 20,178 @ 648.90p Value: £130,935Immupharma (IMM) Director name: Mr Ajay AgrawalAmount sold: 62,169 @ 57.00p Value: £35,436Entertainment One Ltd. (DI) (ETO) Director name: Mr Robert LantosAmount sold: 19,000 @ 176.00p Value: £33,440 Immupharma Experian